Full Court shoots down Boehringer opposition to Merck Sharp & Dohme's parasite patent

Full Court shoots down Boehringer opposition to Merck Sharp & Dohme’s parasite patent

Intellectual Property 2022-05-19 3:38 pm By Cat Fredenburgh | Melbourne

Please login to bookmark

The Full Federal Court has rejected German drug maker Boehringer Ingelheim’s appeal of ruling that shot down its opposition to Merck Sharp & Dohme’s patent application for an injectable anti-parasite drug for livestock.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au